Siga Technologies SIGA
NASDAQ SIGA
$2.97 -0.13 (-4.34%)
At close: Aug 20, 2026 · 12:51 PM UTC

Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025)

Siga Technologies' (SIGA) quarterly Liabilities and Shareholders Equity came in at $219.5 million in Q4 2025, down 10.18% YoY from $244.3 million in Q4 2024, and down 5.24% on a QoQ basis from $231.6 million in Q3 2025.

Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $219.5 million in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 10.18% year-over-year to $219.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $933.5 million (up 6.62% YoY) and the FY2025 annual result came in at $219.5 million, down 10.18% from the prior year.
  • Liabilities and Shareholders Equity fell to $219.5 million in Q4 2025, from $231.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $254.4 million in Q4 2023 to a low of $133.7 million in Q2 2021.
  • A 5-year average of $195.9 million and a median of $195.2 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 50.65% — and 2023, when it fell 22.45%.
  • Tracing SIGA's Liabilities and Shareholders Equity over 5 years: stood at $214.7 million in 2021, then declined by 9.17% to $195.0 million in 2022, then surged by 30.41% to $254.4 million in 2023, then slipped by 3.94% to $244.3 million in 2024, then declined by 10.18% to $219.5 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $219.5 million (Q4 2025), $231.6 million (Q3 2025), and $235.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn - 6.18 Bn
10 Siga Technologies 213.02 Mn 58.06 Mn - 219.47 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 219.47 Mn
Sep 30, 2025 231.60 Mn
Jun 30, 2025 235.33 Mn
Mar 31, 2025 247.07 Mn
Dec 31, 2024 244.34 Mn
Sep 30, 2024 195.35 Mn
Jun 30, 2024 192.66 Mn
Mar 31, 2024 243.15 Mn
Dec 31, 2023 254.35 Mn
Sep 30, 2023 158.38 Mn
Jun 30, 2023 146.51 Mn
Mar 31, 2023 183.92 Mn
Dec 31, 2022 195.04 Mn
Sep 30, 2022 204.22 Mn
Jun 30, 2022 159.94 Mn
Mar 31, 2022 184.55 Mn
Dec 31, 2021 214.73 Mn
Sep 30, 2021 135.56 Mn
Jun 30, 2021 133.69 Mn
Mar 31, 2021 138.77 Mn